Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (464)	3/11/2000 9:08:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 743

<If you don't know when and why a stock will go up or down, you really should not own it.> You just laid that one out for me didn't you, heheh. Gliatech, a biotech with products, has the H3 program, Perceptin, and AD R&D. If Dr_C aka Dr_D can make a case for $600 and not get laughed off the threads, one can make a case for $100 pretty easy...and we have talked about them getting taken out on the cheap by Janssen around $50. There is always a chance the shorts are on to something, but seems very unlikely. A good bet. Cnsi, one that should not be on the otc.bb, and probably should be five bucks right here right now at a miniumum. One of the last screaming bargains, and the CEO seemed nice to boot. If I don't sell to soon (and I always do so why stop after a double or triple) this could work out very nicely five years from now. An outstanding bet. Genset--If I were Venter I'd buy them right now with all that pumped-up stock. When we finally hear what Corixa is having them map out, genxy will have a nice run. A pretty good bet at these prices, mine are paid for several times over. Targeted Genetics--the most likeable CEO you are going to find, no BS--they will cure diseases. They might not cure CF, the E1A program might not lead to cancer cures, the venture with Elan, Emerald Gene, may not pay off for years, and the AIDS vaccine may not work. But I'll bet they go one or two for four...plus whatever they add over the years ahead, R.A. of course, interesting. I loved it at 1 1/2, and we know $15 is fair, coz the smart money is in around there. Should I go on? Cadus, totally stole this idea from the gurus, shame on me for saying anything at all about it--shame on me for spouting about any stocks, because I will feel bad if any of these blow up on me. My kdus shares are paid for a few times over, and if I ever sell a single share, that would be a shame. Synaptic...okay, maybe there is too much neuro in my account. But this seems like the stealth play of the year...or they get bought out. Elan, Aventis, Shering Plough...pharma seems to be coming back a bit, Elan showed up as McCamants pick in Worth when I got my mag today. Cool. How was that? <<If you don't know when and why a stock will go up or down, you really should not own it.> And that is also why, just as soon as I bought into BNI, WM, and JCP I got out just as fast. Buying value just because it is "value" and abandoning what has worked these past few months would be premature. There will be a time to raise cash and buy some dividend stocks, but I do not think now is the time. And if I blow it, I can always blame Greenspan. After all, he is the smart guy not me.